Clorox (CLX) shares have been in the spotlight after the company's latest financial performance updates, drawing attention from investors seeking steady household product stocks. In the past month, ...

The Clorox Company has corrected inventory imbalances from migrating its U.S. supply chain and other business operations to a new enterprise resource planning system, executives told investors during ...

Silence Therapeutics is advancing its lead RNAi drug, divesiran, for polycythemia vera, with a fully enrolled Phase 2 trial and results expected in Q3 2026. SLN boasts a strong cash position ($100M+), ...

The Clorox Company (CLX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...